Clicky

argenx SE(ARGX) News

Date Title
Nov 28 These 2 Stocks Are Falling in a Fading Rally
Nov 28 UPDATE 2-November rally in European stocks stalls after comments from ECB officials
Nov 28 argenx Reports Topline Results from ADVANCE-SC Study of VYVGART Hytrulo in Primary Immune Thrombocytopenia
Oct 5 IQVIA (IQV) and argenx Partner to Advance Autoimmune Care
Sep 21 argenx Announces VYVGART (efgartigimod alfa) Authorized for Sale by Health Canada for Generalized Myasthenia Gravis
Sep 17 New S&P 500 Entrant Airbnb And DKNG Lead 5 Stocks Near Buy Points
Sep 15 How IBD Stock Of The Day Argenx, A Top-Notch Biotech, Is Dominating — With One Drug
Sep 15 argenx Announces Positive CHMP Opinion for Subcutaneous Efgartigimod for Generalized Myasthenia Gravis
Aug 9 Halozyme (HALO) Q2 Earnings & Revenues Beat, 2023 View Raised